Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | cGMP-specific 3',5'-cyclic phosphodiesterase | ||
| Ligand | BDBM50300953 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_788276 (CHEMBL1919539) | ||
| IC50 | 0.050000±n/a nM | ||
| Citation |  Hughes, RO; Maddux, T; Joseph Rogier, D; Lu, S; Walker, JK; Jon Jacobsen, E; Rumsey, JM; Zheng, Y; Macinnes, A; Bond, BR; Han, S Investigation of the pyrazinones as PDE5 inhibitors: evaluation of regioisomeric projections into the solvent region. Bioorg Med Chem Lett21:6348-52 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| cGMP-specific 3',5'-cyclic phosphodiesterase | |||
| Name: | cGMP-specific 3',5'-cyclic phosphodiesterase | ||
| Synonyms: | 3',5'-cyclic phosphodiesterase | CGB-PDE | PDE5 | PDE5A | PDE5A_HUMAN | Phosphodiesterase 2 and 5 (PDE2 and PDE5) | Phosphodiesterase 5 (PDE5) | Phosphodiesterase 5A | Phosphodiesterase 5A (PDE5A) | cGMP-binding cGMP-specific phosphodiesterase | cGMP-specific 3',5'-cyclic phosphodiesterase | ||
| Type: | Protein | ||
| Mol. Mass.: | 99975.83 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | O76074 | ||
| Residue: | 875 | ||
| Sequence: |
| ||
| BDBM50300953 | |||
| n/a | |||
| Name | BDBM50300953 | ||
| Synonyms: | 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one | CHEMBL567470 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C24H31N5O4 | ||
| Mol. Mass. | 453.534 | ||
| SMILES | CCCOCCn1c2cc(ncc2nc(N[C@H]2CC[C@H](O)CC2)c1=O)-c1ccc(OC)nc1 |r,wU:16.16,wD:19.20,(24.97,-.51,;23.64,-1.28,;23.64,-2.82,;22.3,-3.59,;22.3,-5.13,;20.97,-5.9,;20.97,-7.44,;22.3,-8.21,;23.62,-7.45,;24.95,-8.21,;24.95,-9.75,;23.62,-10.52,;22.3,-9.75,;20.97,-10.52,;19.62,-9.75,;18.29,-10.51,;16.96,-9.74,;15.63,-10.51,;14.29,-9.73,;14.3,-8.19,;12.97,-7.41,;15.64,-7.43,;16.97,-8.2,;19.64,-8.21,;18.31,-7.44,;26.28,-7.43,;27.61,-8.2,;28.94,-7.43,;28.94,-5.89,;30.27,-5.11,;31.61,-5.87,;27.59,-5.12,;26.27,-5.9,)| | ||
| Structure | 
| ||